{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:03:46Z","timestamp":1785859426964,"version":"3.56.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,12,27]]},"DOI":"10.1097\/01.tp.0000188300.26762.74","type":"journal-article","created":{"date-parts":[[2005,12,23]],"date-time":"2005-12-23T04:06:53Z","timestamp":1135310813000},"page":"1734-1741","source":"Crossref","is-referenced-by-count":96,"title":["Two Corticosteroid-Free Regimens\u2014Tacrolimus Monotherapy after Basiliximab Administration and Tacrolimus\/Mycophenolate Mofetil\u2014in Comparison with a Standard Triple Regimen in Renal Transplantation: Results of the Atlas Study"],"prefix":"10.1097","volume":"80","author":[{"given":"Stefan","family":"V\u00edtko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian","family":"Klinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaija","family":"Salmela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zbigniew","family":"Wlodarczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Tyd\u00e8n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz","family":"Senatorski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Ostrowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Fauchald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franciszek","family":"Kokot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Stefoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferenc","family":"Perner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Claesson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Castagneto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Heemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Carmellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Squifflet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Segoloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"B\u00e4ckman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heide","family":"Sperschneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard K.","family":"Kr\u00e4mer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-18-20210129","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1046\/j.1523-1755.2002.00491.x","article-title":"Five preventable causes of kidney graft loss in the 1990s: a single-center analysis.","volume":"62","author":"Matas","year":"2002","journal-title":"Kidney Int"},{"key":"R2-18-20210129","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2165\/00063030-200115040-00006","article-title":"Risk factors for and management of post-transplantation cardiovascular disease.","volume":"15","author":"Fellstrom","year":"2001","journal-title":"BioDrugs"},{"key":"R3-18-20210129","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMra011295","article-title":"Strategies to improve long-term outcomes after renal transplantation.","volume":"346","author":"Pascual","year":"2002","journal-title":"N Engl J Med"},{"key":"R4-18-20210129","first-page":"SS5","article-title":"Causes of late renal allograft loss: chronic allograft dysfunction, death, and other factors.","volume":"71","author":"Kreis","year":"2001","journal-title":"Transplantation"},{"key":"R5-18-20210129","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1046\/j.1523-1755.2000.00816.x","article-title":"Long-term survival in renal transplant recipients with graft function.","volume":"57","author":"Ojo","year":"2000","journal-title":"Kidney Int"},{"issue":"Suppl. 6","key":"R6-18-20210129","first-page":"19","article-title":"Overview of the side effects of corticosteroid therapy.","volume":"9","author":"Ansell","year":"1991","journal-title":"Clin Exp Rheumatol"},{"key":"R7-18-20210129","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0140-6736(02)07875-3","article-title":"Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: a randomised multicentre study.","volume":"359","author":"Margreiter","year":"2002","journal-title":"Lancet"},{"key":"R8-18-20210129","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/S0041-1345(02)02942-1","article-title":"Chronic rejection and graft half-life: five-year follow-up of the European tacrolimus multicenter renal study.","volume":"34","author":"Mayer","year":"2002","journal-title":"Transplant Proc"},{"key":"R9-18-20210129","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/00007890-199708150-00012","article-title":"Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection.","volume":"64","author":"Mayer","year":"1997","journal-title":"Transplantation"},{"key":"R10-18-20210129","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/00007890-200203150-00021","article-title":"A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: evidence for improved allograft survival at five years.","volume":"73","author":"Vincenti","year":"2002","journal-title":"Transplantation"},{"key":"R11-18-20210129","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/S0041-1345(02)02960-3","article-title":"Efficacy and safety of tacrolimus compared with cyclosporine microemulsion in kidney transplantation: Twelve-month follow-up.","volume":"34","author":"Montagnino","year":"2002","journal-title":"Transplant Proc"},{"key":"R12-18-20210129","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/S0041-1345(02)03032-4","article-title":"Safe withdrawal of corticosteroids or mycophenolate mofetil: results of a large, prospective, multicenter, randomized study.","volume":"34","author":"Squifflet","year":"2002","journal-title":"Transplant Proc"},{"key":"R13-18-20210129","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S0140-6736(97)09278-7","article-title":"Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group.","volume":"350","author":"Nashan","year":"1997","journal-title":"Lancet"},{"key":"R14-18-20210129","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/00007890-199901270-00016","article-title":"Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group.","volume":"67","author":"Kahan","year":"1999","journal-title":"Transplantation"},{"key":"R15-18-20210129","first-page":"28","article-title":"Freedom from rejection and stable kidney function are excellent criteria for steroid withdrawal in tacrolimus-treated kidney transplant recipients.","volume":"7","author":"Wlodarczyk","year":"2002","journal-title":"Ann Transplant"},{"key":"R16-18-20210129","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1097\/01.TP.0000089440.47239.3F","article-title":"Withdrawal of steroid therapy in African American kidney transplant recipients receiving sirolimus and tacrolimus.","volume":"76","author":"Hricik","year":"2003","journal-title":"Transplantation"},{"key":"R17-18-20210129","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1097\/00007890-200212270-00011","article-title":"Early steroid withdrawal in renal transplantation with tacrolimus dual therapy: a pilot study.","volume":"74","author":"Boots","year":"2002","journal-title":"Transplantation"},{"key":"R18-18-20210129","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/S0041-1345(02)02991-3","article-title":"Steroid withdrawal from tacrolimus-based therapy in renal transplant patients.","volume":"34","author":"Citterio","year":"2002","journal-title":"Transplant Proc"},{"key":"R19-18-20210129","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1034\/j.1399-0012.2003.00038.x","article-title":"The use of an anti-CD25 monoclonal antibody and mycophenolate mofetil enables the use of a low-dose tacrolimus and early withdrawal of steroids in renal transplant recipients.","volume":"17","author":"Kuypers","year":"2003","journal-title":"Clin Transplant"},{"key":"R20-18-20210129","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/S0041-1345(02)02983-4","article-title":"Low-dose and rapid steroid withdrawal in renal transplant patients treated with tacrolimus and mycophenolate mofetil.","volume":"34","author":"Sota","year":"2002","journal-title":"Transplant Proc"},{"key":"R21-18-20210129","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0041-1345(98)00280-2","article-title":"Outcome after steroid withdrawal in renal transplant patients receiving tacrolimus-based immunosuppression.","volume":"30","author":"Shapiro","year":"1998","journal-title":"Transplant Proc"},{"key":"R22-18-20210129","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1097\/00007890-200104270-00014","article-title":"Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: three-year follow-up.","volume":"71","year":"2001","journal-title":"Transplantation"},{"key":"R23-18-20210129","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1177\/152216280100400406","article-title":"Infectious disease issues in the well transplant patient.","volume":"4","author":"Baden","year":"2001","journal-title":"Graft"},{"key":"R24-18-20210129","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/S0041-1345(02)03082-8","article-title":"Patients with high cholesterol levels benefit most from early withdrawal of corticosteroids.","volume":"34","author":"Rigotti","year":"2002","journal-title":"Transplant Proc"},{"key":"R25-18-20210129","first-page":"155","article-title":"Medication noncompliance in patients with chronic disease: issues in dialysis and renal transplantation.","volume":"9","author":"Loghman-Adham","year":"2003","journal-title":"Am J Manag Care"},{"key":"R26-18-20210129","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1016\/S0041-1345(02)03403-6","article-title":"Noncompliance as a cause of renal graft loss.","volume":"34","author":"Michelon","year":"2002","journal-title":"Transplant Proc"},{"key":"R27-18-20210129","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1097\/00007890-200111150-00019","article-title":"Noncompliance after solid organ transplantation.","volume":"72","author":"Jindal","year":"2001","journal-title":"Transplantation"},{"key":"R28-18-20210129","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2165\/00003495-200262040-00002","article-title":"Issues of adherence to immunosuppressant therapy after solid-organ transplantation.","volume":"62","author":"Chisholm","year":"2002","journal-title":"Drugs"},{"key":"R29-18-20210129","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/S0041-1345(98)00281-4","article-title":"Corticosteroid cessation 1 week following renal transplantation using tacrolimus\/mycophenolate mofetil based immunosuppression.","volume":"30","author":"Grewal","year":"1998","journal-title":"Transplant Proc"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00003453-200144120-00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:10:58Z","timestamp":1785856258000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007890-200512270-00018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12,27]]},"references-count":29,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1097\/01.tp.0000188300.26762.74","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12,27]]}}}